Join
Live feed
·
INSIDERFilingvia Quantisnow
Travere Therapeutics Inc. logo

Director Baynes Roy D. exercised 4,500 shares at a strike of $18.27 and sold $209,925 worth of shares (4,500 units at $46.65) as part of a pre-agreed trading plan (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TVTX (Travere Therapeutics Inc.) and more on Quantisnow.